Results 81 to 90 of about 112,020 (111)

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

Medical Devices: Evidence and Research, 2020
Aino Fianu Jonasson,1 Marie Bixo,2 Inger Sundström Poromaa,3 Mikael Åstrom4 1Department of Clinical Sciences, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institute, Stockholm, Sweden; 2Department of Clinical ...
Fianu Jonasson A, Bixo M, Sundström Poromaa I, Åstrom M   +3 more
doaj  

Candidíase vulvovaginal

, 2014
Material utilizado na unidade 3 do Curso Autoinstrucional de Capacitação em Atenção Integral à Saúde Sexual e Reprodutiva II, produzido pela UNA-SUS/UFMA e voltado para os médicos que atuam na Atenção Básica.
Universidade Federal do Maranhão - UNA-SUS/UFMA
core  

Efficacy and safety of ultra-low-dose Vagifem (10 mcg)

Patient Preference and Adherence, 2011
Janet A Chollet1,2 1Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Pear Tree Pharmaceuticals, Waltham, MA, USA Abstract: Vulvovaginal atrophy [VVA] is defined as inflammation of the vaginal epithelium due to atrophy secondary to decreased levels
Chollet JA
doaj  

Vulvovaginal atrophy: current methods of diagnosis and treatment

Бюллетень сибирской медицины
Aim. To review modern methods of diagnosis and treatment of vulvovaginal atrophy (VVA), which is one of the manifestations of genitourinary syndrome of menopause in periand postmenopausal women.Materials and methods.
L. F. Zainetdinova, L. F. Telesheva, B. I. Medvedev, V. V. Khakhulina   +3 more
doaj   +1 more source

Vaginal LASER and estrogen comparison in Genitourinary Syndrome of Menopause

Continence
Aim:: This study aims to compare the efficacy of CO2 fractionated laser therapy and topical estrogen treatment in managing Genitourinary Syndrome of Menopause (GSM).
Aytaj Jafarzade, Aydan Biri, Osman Ufuk Ekiz, Tamer Mungan   +3 more
doaj   +1 more source

Dyspareunia in women in preand postmenopausal period [PDF]

Гинекология, 2016
The article presents current views on the multiple pathogenetic mechanisms of development of dyspareunia in women in pre - and postmenopausal women with positions of biopsychosocial approach.
A I Fedorova
doaj  

Vulvovaginal atrophy after gynecological cancer: etiology, epidemiology, diagnostics and management (review of the literature). [PDF]

Aim: Review the etiology, epidemiology, diagnostics and treatment options of vulvovaginal atrophy that occurs following oncogynecologic treatment. Objectives: 1) Describe etiology; 2) Investigate prevalence and risk factors; 3) Describe diagnostic ...
Narutytė, Ramunė,
core  

DT56a (Femarelle) effectively manages vulvovaginal atrophy in postmenopausal women

Gynecological Endocrinology
Objective To examine the effect of DT56a (Femarelle®), a non-hormonal oral treatment for the management of menopause, on symptoms of vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) in postmenopausal women.Methods Twelve (n = 12 ...
Margaret Nachtigall, Lila E. Nachtigall
doaj   +1 more source

Features of the vaginal microbiome in postmenopausal vulvovaginal atrophy

Медицинский вестник Юга России
Objective: to study the features of the vaginal microbiome in women with postmenopausal OVA and to conduct a comparative analysis of the microbiota in groups with varying degrees of severity of symptoms.Materials and methods: a prospective study was ...
M. I. Biryukova, I. I. Kutsenko, E. I. Kravtsova   +2 more
doaj   +1 more source

Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination

International Journal of Women's Health, 2013
Sebastian Mirkin,1 James H Pickar21Pfizer Inc, Collegeville, PA, 2Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USAAbstract: Loss of estrogen production in women during menopause results in a state of estrogen
Mirkin S, Pickar JH
doaj